Filing Details
- Accession Number:
- 0001808805-22-000099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-26 21:26:42
- Reporting Period:
- 2022-09-23
- Accepted Time:
- 2022-09-26 21:26:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1808805 | Nautilus Biotechnology Inc. | NAUT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1378831 | E Gwen Weld | C/O Nautilus Biotechnology, Inc. 2701 Eastlake Avenue East Seattle WA 98102 | Chief People Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-23 | 30,000 | $2.03 | 30,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 30,000 shares purchased in the price range of $1.97 to $2.0257 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
